Is arteriolar vacuolization a predictor of calcineurin inhibitor nephrotoxicity?

Clinical Transplantation

Volumn 25, Issue SUPPL. 23, 2011, Pages 23-27

  Horike, Keiji ^a   Takeda, Asami ^a   Yamaguchi, Yutaka ^b   Ogiyama, Yoshiaki ^a   Yamauchi, Yukako ^a   Murata, Minako ^a   Kawaguchi, Takehiko ^a   Suzuki, Taisei ^a   Otsuka, Yasuhiro ^a   Inaguma, Daijyo ^a   Goto, Norihiko ^a   Watarai, Yoshihiko ^a   Uchida, Kazuharu ^a   Morozumi, Kunio ^a  

^a NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^b Yamaguchi's Pathology Laboratory   (Japan)

Author keywords

Alternative arteriolar hyalinosis; Arteriolar vacuolization; Calcineurin inhibitor; CNI nephrotoxicity; Renal biopsy

Indexed keywords

CALCINEURIN INHIBITOR;

ADULT; ARTERIOLE; BIOPSY; CELL VACUOLE; CONTROLLED STUDY; FEMALE; HISTOLOGY; HISTOPATHOLOGY; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; NOTE; PREDICTOR VARIABLE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ARTERIOLES; CALCINEURIN; CYCLOSPORINE; FEMALE; GRAFT REJECTION; HUMANS; HYALIN; IMMUNOSUPPRESSIVE AGENTS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TACROLIMUS; VACUOLES;

EID: 79957597088     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2011.01474.x     Document Type: Note

References (14)

1. Helderman JH, Van Buren DH, Amend WJ Jr, Pirsch JD. Chronic immunosuppression of the renal transplant patient. J Am Soc Nephrol 1994: 4: S2.
2. Mihatsch MJ, Morozumi K, Strøm EH, Ryffel B, Gudat F, Thiel G. Renal transplant morphology after long-term therapy with cyclosporine. Transplant Proc 1995: 27: 39.
3. Mihatsch MJ, Thiel G, Ryffel B. Histopathology of cyclosporine nephrotoxicity. Transplant Proc 1988: 20: 759.
4. Morozumi K, Takeda A, Uchida K, Mihatsch MJ. Cyclosporine nephrotoxicity: how does it affect renal allograft function and transplant morphology?. Transplant Proc 2004: 36: 251S.
5. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Chapman JR, Allen RD. Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology. Transplantation 2004: 78: 557.
6. Heptinstall's pathology of the kidney, 6th edn. LWW, Philadelphia, 2007. Chapter 28: Renal Transplant Pathology. p. 1429.
7. Uchida K, Tominaga Y, Haba T, et al. Usefulness of monitoring of AUC(0-4h) during the induction period of immunosuppressive therapy with tacrolimus after renal transplantation. Transplant Proc 2002: 34: 1736.
8. Remuzzi G, Perico N. Cyclosporine-induced renal dysfunction in experimental animals and humans. Kidney Int Suppl 1995: 52: S70.
9. Fasel J, Kaissling B, Ludwig KS, Ryffel B, Mihatsch MJ. Light and electron microscopic changes in the kidney of Wistar rats following treatment with cyclosporine A. Ultrastruct Pathol 1987: 11: 435.
10. Katari SR, Magnone M, Shapiro R, et al. Tacrolimus nephrotoxicity after renal transplantation. Transplant Proc 1997: 29: 311.
11. Sis B, Dadras F, Khoshjou F, Cockfield S, Mihatsch MJ, Solez K. Reproducibility studies on arteriolar hyaline thickening scoring in calcineurin inhibitor-treated renal allograft recipients. Am J Transplant 2006: 6: 1444.
12. Yamaguchi Y, Teraoka S, Yagisawa T, Takahashi K, Toma H, Ota K. Ultrastructural study of cyclosporine-associated arteriolopathy in renal allografts. Transplant Proc 1989: 21: 1517.
13. Collins BS, Davis CL, Marsh CL, McVicar JP, Perkins JD, Alpers CE. Reversible cyclosporine arteriolopathy. Transplantation 1992: 54: 732.
14. Morozumi K, Thiel G, Albert FW, Banfi G, Gudat F, Mihatsch MJ. Studies on morphological outcome of cyclosporine-associated arteriolopathy after discontinuation of cyclosporine in renal allografts. Clin Nephrol 1992: 38: 1.